Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. www.ncbi.nlm.nih.gov › pmc › articlesPolyvalent therapeutic vaccine for type 2 diabetes mellitus ...

   www.ncbi.nlm.nih.gov › pmc › articles

   23 Ιουλ 2020 · In this study, we hypothesize the development of potential immunotherapeutic vaccine candidates for the activation and secretion of cytokines (IL-1, IL-3, and IL-7) to facilitate glucose absorption and cure T2DM.

   • Open in a Separate Window

     Type 2 diabetes mellitus (T2DM) is a worldwide disease that...

   • PMC Free Article

     MATERIALS AND METHODS. The 3Drefine protocol refines the...

   • i3Drefine Software for Protein 3D Structure Refinement and Its Assessment in Casp10

     Introduction. The biennial community-wide Critical...

2. www.ncbi.nlm.nih.gov › pmc › articlesCiticoline and Vitamin B12 Eye Drops in Type 1 Diabetes: Results...

   www.ncbi.nlm.nih.gov › pmc › articles

   16 Μαρ 2020 · The main goal of the study was to evaluate whether or not treatment with eye drops containing citicoline and vitamin B 12 induces changes in the function of RGCs through FDT, in patients with DM1 with mild signs of non-proliferative diabetic retinopathy (NPDR) during a 3-year follow-up.

3. bmcmolcellbiol.biomedcentral.com › articles › 10Polyvalent therapeutic vaccine for type 2 diabetes mellitus ...

   bmcmolcellbiol.biomedcentral.com › articles › 10

   • Αποθηκευμένο αντίγραφο

   23 Ιουλ 2020 · In the studies of Zhang et al., 2018 and Zha et al., 2016 reported that cytokine L-1ß is a key proinflammatory substance in T2DM pathogenesis and has shown a reduction in weight gain, improved glucose tolerance and insulin sensitivity, and a lower β-cell loss in their vaccine with predicted peptide epitopes [55, 72].

4. pmc.ncbi.nlm.nih.gov › articles › PMC7221535Type 2 Diabetes Mellitus: A Review of Multi-Target Drugs

   pmc.ncbi.nlm.nih.gov › articles › PMC7221535

   Since type 2 diabetes mellitus (T2DM) is suffered by the majority of diabetic patients (around 90–95%) and often the mono-target therapy fails in managing blood glucose levels and the other comorbidities, this review focuses on the potential drugs acting on multi-targets involved in the treatment of this type of diabetes.

5. pmc.ncbi.nlm.nih.gov › articles › PMC7395393Topical citicoline and vitamin B12 versus placebo in the...

   pmc.ncbi.nlm.nih.gov › articles › PMC7395393

   Aim of this study was to test the hypothesis that an eyedrop containing citicoline and vitamin B12 may stimulate SBP axonal regrowth in patients with diabetes. Methods. The study was a single-centre, randomized, double-blind, placebo-controlled, prospective study on 30 patients with diabetes.

6. www.sciencedirect.com › science › articleType II diabetes mellitus: a review on recent drug ... -...

   www.sciencedirect.com › science › article

   1 Νοε 2020 · The major drug therapy for type II DM comprises of insulin secretagogues, biguanides, insulin sensitizers, alpha glucosidase inhibitors, incretin mimetics, amylin antagonists and sodium-glucose co-transporter-2 (SGLT2) inhibitors.

7. www.bmj.com › content › 381Benefits and harms of drug treatment for type 2 diabetes:...

   www.bmj.com › content › 381

   • Αποθηκευμένο αντίγραφο

   6 Απρ 2023 · Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials. BMJ 2023; 381 doi: https://doi.org/10.1136/bmj-2022-074068 (Published 06 April 2023) Cite this as: BMJ 2023;381:e074068. Article. Related content. Metrics. Responses. Peer review. Qingyang Shi, research fellow 1,